Our 2026 Doheny Distinguished Lecture Series (DLS) April lecture will be delivered by Vladimir Kefalov, PhD, on Friday, April 10, 2026.

Because of the support of our community, Doheny continues to lead breakthroughs in retinal care. On Monday, April 20, join us for a special Ask the Doctor conversation with world-renowned retina specialist SriniVas Sadda, MD, FARVO, Director of Artificial Intelligence & Imaging Research.

Reconnect with colleagues at the 2026 ARVO Alumni Reception, May 4, 6–9 PM at Former Saint Craft Kitchen & Taps, Hyatt Regency Denver.

Join us for a special presentation with retina specialist SriniVas Sadda, MD, FARVO, Director of Artificial Intelligence & Imaging Research at Doheny Eye Institute and Professor of Ophthalmology at the David Geffen School of Medicine at UCLA.

Continuing medical education (CME) plays a vital role in improving patient outcomes by ensuring clinicians stay at the forefront of rapidly evolving science and technology.

One year ago, wildfires tore through our local communities, leaving behind unimaginable loss and forever changing the lives of so many families.

Join Us: Cast Your Vote for Stein & Doheny Eye Institutes in the U.S. News & World Report Best Hospitals Survey!

A team of Doheny Eye Institute researchers, Mahesh Agarwal, PhD; Sathishkumar Chandrakumar, PhD; Irene Santiago Tierno, MS; Emma M. Lessieur, MD, PhD; and Kaustabh Ghosh, PhD, recently published important new findings in Diabetes that help explain how diabetic eye disease begins.

December 3 marks the International Day of Persons with Disabilities, a global observance dedicated this year to fostering more inclusive societies where people of all abilities can live with dignity, access, and opportunity.

The Fall 2025 InSight Newsletter issue features: Dr. Lessieur Joins Doheny as a Principal Investigator, Doheny’s Vision Research Matters, In Her Father’s Footsteps — How Dr. Lessieur Found Her Career Path, and more.

A new study published in Aging Cell and co-authored by Doheny scientists, Drs. Sreekumar Parameswaran, Ram Kannan, and Srinivas Sadda shed new light on why some people with neovascular age-related macular degeneration (nAMD) develop permanent vision loss.